Mental Health & Low-Dose Lithium Research Study
Empower the Future of Mental Health: Fund Dr. Sudhir Gadh’s Pioneering Research at Karolinska Institute
Effects of Low-Dose Lithium on Mental Health
Can a Naturally Occurring Mineral Change the Future of Mental Health?
Exploring the Link Between Mental Health and Low-Dose Lithium
Welcome to a trusted source for clear, evidence-based information on nutritional Lithium and its role in brain health, mental well-being, and inflammation regulation. This site is dedicated not only to educating visitors about mental health and low-dose lithium, but also to actively seek funding for groundbreaking research at the Karolinska Institute (KI). We invite you to join us in supporting the Lithium-Inflammation Psychiatry (LIP) Study, a pioneering initiative at KI—home of the Nobel Assembly, Sweden’s leading medical university, and a global authority in neuroscience. The LIP Study will be the first comprehensive investigation into how low-dose nutritional Lithium influences key biomarkers linked to optimal brain function, inflammation, and resilience. Your contribution can directly advance this vital research and help unlock new approaches to mental health and inflammation-related disorders.
The Relationship Between Mental Health and Low-Dose Lithium Offers New Avenues for Discovering Effective Treatment Options
We are honored to be part of the larger scientific team at Sweden’s Karolinksa Institute where the paradigm shifting Lithium-Inflammation-Psych (LIP) Study will occur pending funding in 2026. The public health impact of this research cannot be overstated. Personality disorders like BPD impose enormous costs on society – a recent study found that direct healthcare and productivity losses for BPD patients averaged $40,000 per patient, over 16 times higher than for matched individuals without BPD pubmed.ncbi.nlm.nih.gov. Much of this cost stems from chronic disability, repeated hospitalizations or crisis visits, and extensive medication use (often with side effects requiring additional care). Contact Sudhir Gadh for more information about the Lithium Inflammation Psychiatry (LIP) research study at the Karolinska Institute.
Expected Impact and Funding Appeal
- Paradigm-Changing Knowledge: Supporting our research on mental health and low-dose Lithium could present further evidence on whether inflammation is a viable therapeutic target in psychiatry. Positive results could spur a new line of treatment development, magnifying this single trial's impact across the field.
LIP Study News & Announcements
Read the Lithium Inflammation Psychiatry (LIP) Research Study at Karolinska Institute (PDF)
Learn about the LIP research study on Low-Dose Lithium for mental health.
The HILL Model: Treating Concussion Neuroinflammation with Low-Dose Lithium
Discover The HILL Model for concussion treatment & neuroprotection.
Meet the Lithium Inflammation Psychiatry Research Team from the Karolinska Institute (KI)
Join us in advancing the Lithium Inflammation Psychiatry (LIP) study.